Keywords: genmab, reaches, next, gsk, milestone, danish, biotechnology

Genmab reaches next GSK milestone

Article | 01 September 2008

Danish biotechnology firm Genmab will receive a 232.7 million kroner ($45.9 million) milestone payment for ofatumumab (HuMax-CD20), under the terms of its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

GlaxoSmithKline

GSK

Go to company listing